Pharmacy Times
JULY 16, 2025
The shift away from thimerosal may increase the use of single-dose syringes, impacting vaccination practices in various healthcare settings. ACIP's recommendations are increasingly significant for pharmacies, influencing vaccination planning, billing, and patient care activities.
Pharmacy Times
AUGUST 6, 2025
Parental vaccine hesitancy, fueled by misinformation and logistical barriers, contributes to lower immunization rates and increased exemption rates. Parental vaccine hesitancy, fueled by misinformation and logistical barriers, contributes to lower immunization rates and increased exemption rates.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JUNE 20, 2025
Expanding use of the 15-valent pneumococcal conjugate vaccine (PCV15) or 20-valent pneumococcal conjugate vaccine (PCV20) to all United States adults aged 50 to 64 years would result in modest budget increases over a 3-year period.
Pharmaceutical Technology
AUGUST 5, 2025
Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News GSK’s world-first gonorrhoea vaccine launched in England The immunisation programme aims to reduce rising gonorrhoea rates and address antibiotic-resistant strains. GSK’s 4CMenB is not a newly approved vaccine.
Pharmacy Times
JULY 25, 2025
Increased awareness of infectious diseases during the pandemic may have improved vaccine uptake among Medicare enrollees, while service reductions and vaccine hesitancy affected Medicaid enrollees.
Pharma Times
JULY 23, 2025
Dr Catherine Caulfield, CEO of Ovagen said: “What we have developed isn’t incremental, it’s a complete rethink of the vaccine manufacturing process. Our germ free egg platform eliminates bacterial contamination and reduces the need for antibiotics in vaccine production, while delivering significantly higher viral yield.
Pharma Times
JULY 10, 2025
The results, now published in Vaccines , show that the combination was well-tolerated with no serious adverse events, and generated strong immune responses. Series A to advance radioligand therapy platform Jul 9, 2025 VarmX secures US approval to begin phase 3 trial of urgent surgery treatment Jul 8, 2025 News alerts This field is required.
Expert insights. Personalized for you.
Let's personalize your content